Original Research
Published on 11 Nov 2025
TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study
in Cancer Immunity and Immunotherapy
- 393 views
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Review
Published on 11 Nov 2025
in Cell Death and Survival
Original Research
Published on 11 Nov 2025
in Adolescent Reproductive Health and Well-being
Review
Published on 11 Nov 2025
in Adaptive immunity in infection
Original Research
Published on 11 Nov 2025
in Family Medicine and Primary Care
Original Research
Published on 11 Nov 2025
in Pediatric Orthopedics
Review
Published on 11 Nov 2025
in Occupational and Environmental Epidemiology
Original Research
Published on 11 Nov 2025
in Digital Manufacturing
Original Research
Published on 11 Nov 2025
in Public Health Policy
Case Report
Published on 11 Nov 2025
in Skin Allergy
Original Research
Published on 11 Nov 2025
in Nutrition and Sustainable Diets
Original Research
Published on 11 Nov 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 11 Nov 2025
in Exercise Physiology
Original Research
Published on 11 Nov 2025
in Medical Physics and Imaging
Original Research
Published on 11 Nov 2025
in Comparative Immunology
Original Research
Published on 11 Nov 2025
in Tissue Engineering and Regenerative Medicine